Arcellx Inc (ACLX)
53.66
-0.13
(-0.24%)
USD |
NASDAQ |
Jun 26, 16:00
53.66
0.00 (0.00%)
After-Hours: 20:00
Arcellx Total Assets (Quarterly): 779.70M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 779.70M |
| December 31, 2023 | 825.13M |
| September 30, 2023 | 614.22M |
| June 30, 2023 | 623.53M |
| March 31, 2023 | 622.94M |
| December 31, 2022 | 313.82M |
| Date | Value |
|---|---|
| September 30, 2022 | 337.33M |
| June 30, 2022 | 375.33M |
| March 31, 2022 | 243.39M |
| December 31, 2021 | 128.78M |
| September 30, 2021 | 144.96M |
| December 31, 2020 | 57.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
57.69M
Minimum
Dec 2020
825.13M
Maximum
Dec 2023
422.23M
Average
356.33M
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences Inc | 56.29B |
| BridgeBio Pharma Inc | 849.33M |
| Eli Lilly and Co | 63.94B |
| AbbVie Inc | 148.87B |
| Blueprint Medicines Corp | 1.038B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 283.12M |
| Shareholders Equity (Quarterly) | 496.57M |
| Current Ratio | 5.456 |